Literature DB >> 21625775

SCA2 presenting as an ataxia-parkinsonism-motor neuron disease syndrome.

Pedro Braga-Neto, José Luiz Pedroso, André Carvalho Felício, Agessandro Abrahão, Lívia Almeida Dutra, Marcio Luiz Escorcio Bezerra, Orlando Graziani Povoas Barsottini.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21625775     DOI： 10.1590/s0004-282x2011000300027

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN： 0004-282X            Impact factor:   1.420


× No keyword cloud information.
  4 in total

1.  Neonatal SCA2 Presenting With Choreic Movements and Dystonia With Dystonic Jerks, Retinitis, Seizures, and Hypotonia.

Authors:  Marcela Amaral Avelino; José Luiz Pedroso; Antonio Orlacchio; Orlando Graziani Povoas Barsottini; Marcelo Rodrigues Masruha
Journal:  Mov Disord Clin Pract       Date:  2014-06-11

2.  Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment.

Authors:  Marcio Luiz Escorcio Bezerra; José Luiz Pedroso; Pedro Braga-Neto; Agessandro Abrahao; Marcus Vinicius Cristino de Albuquerque; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Nadia Iandoli de Oliveira Braga; Gilberto Mastrocola Manzano; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

3.  Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease.

Authors:  Lais M Oliveira; Tara Rastin; Graeme A M Nimmo; Jay P Ross; Patrick A Dion; Ming Zhang; Dayna-Lynn Nevay; David Arkadir; Marc Gotkine; Carolina Barnett; Christen L Shoesmith; Ari Zimran; Ekaterina A Rogaeva; Lorne Zinman; Guy A Rouleau; Ziv Gan-Or; Dominick Amato; Lorraine V Kalia
Journal:  Neurol Genet       Date:  2021-05-18

Review 4.  Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies.

Authors:  Ming-Dong Wang; James Gomes; Neil R Cashman; Julian Little; Daniel Krewski
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.